Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Medicines Discovery Catapult Strengthens Senior Leadership Team with Two Executive Appointments

Medicines Discovery Catapult (MDC), a national Life Sciences service dedicated to driving productivity and impact in drug R&D, has strengthened its Executive team with the appointment of a Chief Commercial Officer and its first Managing Director.

Dr Francesca Sadler has joined MDC as Chief Commercial Officer, bringing over 20 years’ experience in commercialising high-quality scientific services to both UK and international communities.

Nordic Life Science Days 2025 (NLSDays)

Where Nordic life science meets the world

Nordic Life Science Days is the largest life science partnering event in the Nordics. NLSDays gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry. 2024 numbers: • Attracted 1400+ delegates from 30 countries. • Gathered 150+ investors and 120+ speakers and presenters • Gathered 130+ showcasing companies, organizations, and countries. • Enjoyed the support of more than 80 sponsors and partners. 

Optimized plating of bacterial and yeast cells on standard agar plates

EZ-Spread™ Plating Beads from AMSBIO allow you to spread bacterial and yeast cells across the surface of an agar plate in just seconds.

Eliminating the traditional need for glass rods and potentially hazardous ethanol flaming - EZ-Spread plating beads provide a safer and more convenient method for spreading bacterial and yeast cells on agar plates.

Manufactured using precision molds, resulting in uniform shape and diameter, EZ-Spread plating beads ensure more even spreading of cells leading to increased colony formation compared to conventional methods.

Cancer Research Horizons opens nominations for its Innovation and Entrepreneurship Awards 2025

Cancer Research Horizons, the innovation arm of Cancer Research UK, has opened nominations for its Innovation and Entrepreneurship Awards 2025, which celebrate the UK’s most enterprising efforts in oncology by recognising the researchers and entrepreneurs who are making strides towards translating their innovations into effective treatments and diagnostics for the benefit of patients affected by cancer.

PrecisionLife Appoints Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare

OXFORD, UK – 8 January 2025 – PrecisionLife, a leading precision medicine company focused on complex chronic diseases, announces the appointment of Bill Keating as Chief Commercial Officer, Diagnostics and Healthcare to lead the commercialization of precision medicine applications from its range of innovative new Mechanostic® tests in complex chronic diseases. 

Norwich Research Park Innovation Hothouse winners announced

iBoxit, KNEE3D and PfBIO have been named winners at a competition showcasing innovative business ideas at Norwich Research Park.

In collaboration with the University of East Anglia (UEA) and The Royal Society, the Innovation Hothouse competition saw eight finalists pitch their innovative ideas to a panel of expert judges.

All were either spin-out or start-up companies founded by researchers, scientists, entrepreneurs or students based on the park campus.

User Webinar: Solid Form Derisking of PF-06282999 - An Integrated Approach Combining Experimental, Informatics, and Energetic Methods

A recent study published in the Journal of Pharmaceutical Sciences (https://doi.org/10.1016/j.xphs.2024.10.013) analysed the complexities of three-dimensional crystal packing arrangements of small-molecule drug candidates, focusing on the CCDC Solid Form Health Check to assess the risk of thermodynamically stable solid forms during drug development.

Finance Manager

Infex is developing new therapies to meet the rising burden of critical priority infectious disease. Based at Alderley Park in the North West of England, we have a pipeline of drugs in preclinical and clinical development to treat patients suffering from life-threatening infections.

As part of the continued development of the company we are now looking to appoint an enthusiastic Finance Manager to work alongside the CFO and Finance Administrator to provide accurate and up to date financial reporting to the Board and Science Team.

Subscribe to